Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 5768, July 15, 2009. Published Online First July 7, 2009;
doi: 10.1158/0008-5472.CAN-09-0446
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0008-5472.CAN-09-0446v1
69/14/5768    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Halberg, R. B.
Right arrow Articles by Dove, W. F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halberg, R. B.
Right arrow Articles by Dove, W. F.

Cell, Tumor, and Stem Cell Biology

Long-lived Min Mice Develop Advanced Intestinal Cancers through a Genetically Conservative Pathway

Richard B. Halberg1,2, Jesse Waggoner1, Kristen Rasmussen1, Alanna White1, Linda Clipson1, Amy J. Prunuske1, Jeffery W. Bacher5, Ruth Sullivan2,3, Mary Kay Washington6, Henry C. Pitot1, John H.J. Petrini4, Donna G. Albertson7 and William F. Dove1,3,4

1 McArdle Laboratory for Cancer Research, 2 Research Animal Resources Center Comparative Pathology Laboratory, 3 Paul P. Carbone Comprehensive Cancer Center, and 4 Laboratory of Genetics, University of Wisconsin; 5 Genetics Analysis Group, Promega Corporation, Madison, Wisconsin; 6 Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee; and 7 Cancer Research Institute, University of California, San Francisco, California

Requests for reprints: William F. Dove, University of Wisconsin, 1400 University Avenue, Madison, WI 53706. Phone: 608-262-4977; Fax: 608-262-2824; E-mail: dove{at}oncology.wisc.edu.

Key Words: intestinal neoplasia • invasive adenocarcinomas • local metastasis • microsatellite instability • chromosomal instability

C57BL/6J mice carrying the Min allele of Adenomatous polyposis coli (Apc) develop numerous adenomas along the entire length of the intestine and consequently die at an early age. This short lifespan would prevent the accumulation of somatic genetic mutations or epigenetic alterations necessary for tumor progression. To overcome this limitation, we generated F1 ApcMin/+ hybrids by crossing C57BR/cdcJ and SWR/J females to C57BL/6J ApcMin/+ males. These hybrids developed few intestinal tumors and often lived longer than 1 year. Many of the tumors (24-87%) were invasive adenocarcinomas, in which neoplastic tissue penetrated through the muscle wall into the mesentery. In a few cases (3%), lesions metastasized by extension to regional lymph nodes. The development of these familial cancers does not require chromosomal gains or losses, a high level of microsatellite instability, or the presence of Helicobacter. To test whether genetic instability might accelerate tumor progression, we generated ApcMin/+ mice homozygous for the hypomorphic allele of the Nijmegen breakage syndrome gene (Nbs1{Delta}B) and also treated ApcMin/+ mice with a strong somatic mutagen. These imposed genetic instabilities did not reduce the time required for cancers to form nor increase the percentage of cancers nor drive progression to the point of distant metastasis. In summary, we have found that the ApcMin/+ mouse model for familial intestinal cancer can develop frequent invasive cancers in the absence of overt genomic instability. Possible factors that promote invasion include age-dependent epigenetic changes, conservative somatic recombination, or direct effects of alleles in the F1 hybrid genetic background. [Cancer Res 2009;69(14):5768–75]




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. L. Huttlin, X. Chen, G. A. Barrett-Wilt, A. D. Hegeman, R. B. Halberg, A. C. Harms, M. A. Newton, W. F. Dove, and M. R. Sussman
Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution
PNAS, October 6, 2009; 106(40): 17235 - 17240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.